We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
ACNB Corp
ACNB
$662M
| $411K | ﹤0.01% |
10,860
-46
| -0.4% | -$1.62K |
|
|
EEX
2452
DELISTED
Emerald Holding
EEX
| $411K | ﹤0.01% |
38,922
+118
| +0.3% | +$1.17K |
|
2453
Hingham Institution for Saving
HIFS
$667M
| $411K | ﹤0.01% |
1,953
-4
| -0.2% | -$771 |
|
2454
SEACOR Marine Holdings
SMHI
$257M
| $411K | ﹤0.01% |
29,788
+175
| +0.6% | +$2.28K |
|
|
SIEN
2455
DELISTED
Sientra, Inc.
SIEN
| $410K | ﹤0.01% |
4,590
+402
| +10% | +$30.3K |
|
|
BRG
2456
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $410K | ﹤0.01% |
34,025
+1,208
| +4% | +$14.4K |
|
2457
Distribution Solutions Group
DSGR
$1.61B
| $408K | ﹤0.01% |
15,664
-64
| -0.4% | -$1.51K |
|
|
HONE
2458
DELISTED
HarborOne Bancorp
HONE
| $408K | ﹤0.01% |
37,123
+263
| +0.7% | +$2.76K |
|
|
HALL
2459
DELISTED
Hallmark Financial Services, Inc.
HALL
| $408K | ﹤0.01% |
2,322
-8
| -0.3% | -$1.46K |
|
|
KIN
2460
DELISTED
Kindred Biosciences, Inc.
KIN
| $407K | ﹤0.01% |
48,012
+329
| +0.7% | +$2.57K |
|
|
MDR
2461
DELISTED
McDermott International
MDR
| $407K | ﹤0.01% |
601,904
+28,861
| +5% | +$36.9K |
|
2462
Tilly's
TLYS
$127M
| $406K | ﹤0.01% |
33,168
+288
| +0.9% | +$3.04K |
|
|
VSLR
2463
DELISTED
VIVINT SOLAR, INC.
VSLR
| $405K | ﹤0.01% |
55,833
+608
| +1% | +$4.29K |
|
2464
Regional Management Corp
RM
$299M
| $404K | ﹤0.01% |
13,440
+107
| +0.8% | +$3.24K |
|
|
HOME
2465
DELISTED
At Home Group Inc.
HOME
| $404K | ﹤0.01% |
73,487
+515
| +0.7% | +$4.19K |
|
|
ODT
2466
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $403K | ﹤0.01% |
12,409
+44
| +0.4% | +$1.36K |
|
2467
MeiraGTx Holdings
MGTX
$1.16B
| $402K | ﹤0.01% |
20,101
+1,026
| +5% | +$17.6K |
|
|
MDLA
2468
DELISTED
Medallia, Inc.
MDLA
| $402K | ﹤0.01% |
12,935
+4,314
| +50% | +$127K |
|
|
CWBC
2469
Community West Bancshares
CWBC
$700M
| $401K | ﹤0.01% |
18,486
+10
| +0.1% | +$209 |
|
|
FCBP
2470
DELISTED
First Choice Bancorp Common Stock
FCBP
| $401K | ﹤0.01% |
14,879
+72
| +0.5% | +$1.66K |
|
2471
Northrim BanCorp
NRIM
$600M
| $399K | ﹤0.01% |
41,720
+560
| +1% | +$5.36K |
|
|
ONDK
2472
DELISTED
On Deck Capital, Inc.
ONDK
| $397K | ﹤0.01% |
95,776
+602
| +0.6% | +$2.42K |
|
2473
Hurco Companies Inc
HURC
$142M
| $396K | ﹤0.01% |
10,319
+73
| +0.7% | +$2.57K |
|
2474
Mistras Group
MG
$502M
| $394K | ﹤0.01% |
27,599
+173
| +0.6% | +$2.45K |
|
2475
Amalgamated Financial
AMAL
$1.5B
| $392K | ﹤0.01% |
20,160
+53
| +0.3% | +$977 |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.